Skip to main content

Olaparib

Ovarian Cancer
Ovarian Cancer Treatment

Update on PARP Inhibitors & Other Precision Cancer Medicines for Ovarian Cancer

By Dr. C.H. Weaver M.D.Sep 30, 2021
Image placeholder title
Breast Cancer Treatment

PARP Inhibitors improve outcomes in BRCA mutated breast cancer. FDA approves Lynparza for treatment of TNBC and early stage breast cancer.

By Dr. C.H. Weaver M.D.Apr 30, 2022
Prostate Cancer News & Updates
Prostate Cancer Treatment

PARP Inhibitors - Effective in Men with BRCA-Mutant Prostate Cancer

By Dr. C.H. Weaver M.D.Feb 19, 2022
Image placeholder title
Ovarian Cancer Treatment

Lynparza Delays Progression & Significantly Prolongs Survival in Ovarian Cancer

By Dr. C.H. Weaver M.D.Nov 19, 2021
Ovarian Cancer
Ovarian Cancer Overviews

Treatment & Management of Ovarian Cancer

By Dr. C.H. Weaver M.D.Sep 30, 2021
Image placeholder title
Ovarian Cancer Treatment

Rubraca Significantly Improves Ovarian Cancer Treatment

By Dr. C.H. Weaver M.D.Apr 1, 2022